Vanguard Group Inc Denali Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,177,234 shares of DNLI stock, worth $226 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,177,234

Previous 11,312,439 1.2%

Holding current value

$226 Million

Previous $263 Million 23.95%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.96 - $31.05 $2.83 Million - $4.2 Million	-135,205 Reduced 1.2%	11,177,234 $326 Million
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $5.15 Million - $7.99 Million	344,146 Added 3.14%	11,312,439 $263 Million
Q1 2024 May 10, 2024	BUY	$15.83 - $23.35 $2.12 Million - $3.12 Million	133,810 Added 1.24%	10,968,293 $225 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $3.83 Million - $5.49 Million	236,702 Added 2.23%	10,834,483 $233 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $7.32 Million - $10.7 Million	354,798 Added 3.46%	10,597,781 $219 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $2.91 Million - $4.1 Million	124,490 Added 1.23%	10,242,983 $302 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $3.76 Million - $5.6 Million	171,395 Added 1.72%	10,118,493 $233 Million
Q4 2022 Feb 10, 2023	BUY	$26.28 - $33.92 $40.6 Million - $52.4 Million	1,545,067 Added 18.39%	9,947,098 $277 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $2.58 Million - $3.83 Million	99,530 Added 1.2%	8,402,031 $258 Million
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $3.98 Million - $6.7 Million	190,471 Added 2.35%	8,302,501 $244 Million
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $1.44 Million - $2.34 Million	-49,500 Reduced 0.61%	8,112,030 $261 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $296,128 - $382,554	-6,953 Reduced 0.09%	8,161,530 $364 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $25.4 Million - $41 Million	524,353 Added 6.86%	8,168,483 $412 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $384 Million - $600 Million	7,644,130 New	7,644,130 $600 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.72B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Denali Therapeutics Inc. Transaction History